Search Results
Found 1 results
510(k) Data Aggregation
(80 days)
TRIAGE C. DIFFICILE, TRIAGE C. DIFFICILE PANEL, TRIAGE C. DIFFICILE TOXIN A
The Triage® C. difficile test is an enzyme immunoassay used for the detection of Clostridium difficile antigen (glutamate dehydrogenase or common antigen) and Toxin A in human fecal specimens. The test will be offered as two singular tests for each protein. This test is used as an aid in the diagnosis of C. difficile associated disease.
The Triage® C. difficile test is an enzyme immunoassay.
The provided document is an FDA 510(k) clearance letter for the Triage® C difficile Panel. It confirms that the device is substantially equivalent to a legally marketed predicate device. However, this document does not contain any information regarding acceptance criteria, study details, or performance data for the device.
Therefore, I cannot provide the requested information based on the given text. The letter only acknowledges the device's clearance for marketing.
Ask a specific question about this device
Page 1 of 1